Beijing Cancer Hospital

Beijing, P.R. 100036

0 studies enrolling now · 1 studies all time

What they study most

Kidney Neoplasms

Studies at this site

• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — Completed